Provided by Tiger Trade Technology Pte. Ltd.

CorMedix Inc.

12.02
+0.10000.84%
Post-market: 11.98-0.0387-0.32%17:45 EST
Volume:3.68M
Turnover:44.18M
Market Cap:947.04M
PE:5.34
High:12.08
Open:11.86
Low:11.75
Close:11.92
52wk High:17.43
52wk Low:5.60
Shares:78.79M
Float Shares:73.69M
Volume Ratio:1.32
T/O Rate:5.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.25
EPS(LYR):-0.3046
ROE:75.08%
ROA:15.68%
PB:2.53
PE(LYR):-39.47

Loading ...

Is CorMedix Still Attractive After 45% YTD Surge and Strong Cash Flow Outlook?

Simply Wall St.
·
Yesterday

CorMedix Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Yesterday

BRIEF-Cormedix Reports Positive Data From Real World Study of Defencath

Reuters
·
Dec 18

CorMedix Reports Positive Interim Results from Real-World DefenCath Study in Hemodialysis Patients

Reuters
·
Dec 18

CorMedix Director Steven W. Lefkowitz Reports Sale of Common Shares

Reuters
·
Dec 11

Assessing CorMedix (CRMD) Valuation Following Recent Share Price Pullback

Simply Wall St.
·
Nov 23

CorMedix price target raised to $18 from $17 at H.C. Wainwright

TIPRANKS
·
Nov 13

U.S. RESEARCH ROUNDUP-Abbvie, BristolMyers Squibb, Diversified Healthcare

Reuters
·
Nov 13

Talphera Raises $17 Million in Private Placement Led by CorMedix

Reuters
·
Nov 13

Talphera Reports Third Quarter 2025 Results and Announces $17 Million Financing

Reuters
·
Nov 13

CorMedix Is Maintained at Buy by Needham

Dow Jones
·
Nov 13

BUZZ-U.S. STOCKS ON THE MOVE-Floor & Decor, Starbucks, gold miners

Reuters
·
Nov 12

Stock Track | CorMedix Soars 12.60% on Strong Q3 Results and Raised 2025 Guidance

Stock Track
·
Nov 12

CorMedix Shares Reverse Premarket Course, Last Down 1.3%

THOMSON REUTERS
·
Nov 12

BUZZ-U.S. STOCKS ON THE MOVE-ExxonMobil, Yatra, Venture Global

Reuters
·
Nov 12

UPDATE: Cormedix Q3 Adj. EPS $0.57 Misses $0.65 Estimate. Adj EPS Excludes One-time Tax Benefit $59.7M

Benzinga
·
Nov 12

CorMedix Swings to Q3 Profit, Revenue Rises; Lifts Full-Year Guidance

MT Newswires Live
·
Nov 12

Stock Track | CorMedix Soars 9.47% Pre-Market on Strong Q3 Results and Raised Guidance

Stock Track
·
Nov 12

Stock Track | CorMedix Soars 9.47% Pre-Market on Stellar Q3 Results and Raised Guidance

Stock Track
·
Nov 12

Biopharma firm CorMedix's Q3 net income beats expectations

Reuters
·
Nov 12